Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2Other 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 12Colonic Neoplasms 5Pain, Postoperative 3Liver Neoplasms 3Stomach Neoplasms 2Inflammatory Bowel Diseases 2Diverticulitis 2Agnosia 2Recurrence 1Rectal Neoplasms 1Patient Satisfaction 1Pancreatic Neoplasms 1Pain 1Neuropathy, Painful 1Neuralgia 1Neoplasm Metastasis 1Inflammation 1Ileus 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Constipation 1Cold Hypersensitivity 1Carcinoma, Hepatocellular 1

Interventions

Acupuncture Therapy 4Sufentanil 3Radiotherapy 3Psychiatric Rehabilitation 3Early Intervention, Educational 3Analgesia 3trimebutine 3-thiocarbamoylbenzenesulfonate 2Yoga 2Transcutaneous Electric Nerve Stimulation 2Therapeutics 2Surveys and Questionnaires 2Ropivacaine 2Palliative Care 2Morphine 2Interviews as Topic 2Ethanol 2Esketamine 2Electroacupuncture 2Capecitabine 2Uncertainty 1Transcranial Magnetic Stimulation 1Sensitivity Training Groups 1Saline Solution 1Psychosocial Intervention 1Oxycodone 1Minocycline 1Methods 1Mental Status and Dementia Tests 1Meditation 1Massage 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pain × Lidocaine × Gastrointestinal × Clear all
NCT07034950 2025-09-11

Effective Dose and Safety of Esketamine During Ultrasound-guided Hepatic Tumor Thermal Ablation

The First Affiliated Hospital of Xiamen University

Phase 1/2 Active not recruiting
79 enrolled
Gastrointestinal

Liver Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡